Lab 2 Immunohaematology

Embed Size (px)

Citation preview

IMMUNOHAEMATOLOGY 411 LAB #2 24th March, 2015Lorraine Thompson 00025062

Title: Tube Test for the Determination for Weak D

Introduction: The objective of this lab is to determine if the weak expression of D antigen is present using an indirect antiglobulin test. The Weak D test is performed in order to detect weak expression of the D antigen on red cells, when the cells being tested have failed to react with anti-D at the immediate spin phase. The red cells in question are incubated at 37 oC with anti-D and then tested with anti-human globulin (AHG) reagent. If the D antigen is present on the cells, the anti-D will sensitize the cells, resulting in agglutination at either the 37 phase or the AHG phase. Lack of agglutination at both phases indicates the D antigen is not present on the red cells. Weak D testing is used to ensure Rh negative donors are truly D negative. It is done on all prenatal patients and candidates for Rh immune globulin. After the A and B antigens, the D (Rh) antigen is the most important red cell antigen in transfusion practice. The D antigen is highly immunogenic and will stimulate antibody production in 80% of D negative recipients receiving D positive red cells. It is necessary to detect weakened expression of the D antigen in certain populations in order to prevent the formation of anti-D in Rh negative individuals. Some red cells possess the D antigen but it is expressed so weakly that the cells are not agglutinated directly by anti-D sera. An indirect antiglobulin test is necessary to identify patients with the Weak D phenotype. There are three theories behind the weak expression of the D antigen: 1) Amount of D epitopes on the red cells. 2) Position of the D allele to the C allele. 3) Inheritance of Partial or Altered parts of the D antigen. It may or may not be done routinely on Rh negative candidates for transfusion, depending on the policy of the transfusing institution. If routine weak D testing is done, weak D positive patients should receive Rh positive blood.

Apparatus/ Materials: 3 EDTA Blood samples of unknown blood type Monoclonal or polyclonal Anti-A Monoclonal or polyclonal Anti-B 2%-5% A cells reagent commercially prepared 2%-5% B cells reagent commercially prepared Anti-D reagent Rh control reagent or gamma clone control Anti-IgG Check Cells 0.9 Saline

10% Bleach solution Beaker Test tubes Test tube rack Pipettes 37oC Incubator BD Sero-Fuge Sharpie permanent maker

Method:1. Labelled test tubes to perform ABO type test and Rh test for 3 Patients EDTA samples2. Prepared a washed, 2-5% suspension of patient cells, performed an ABO type and Rh type3. Recorded the ABO, D and DC results. If the Rh test is negative, continue with step 4 .4. Incubated the D and DC tubes at 37oC for 15 minutes.5. Centrifuged both test tubes and read for agglutination. If the Rh test is negative, continue with step 6.6. Washed both tubes once with saline and decant the supernatant completely and blot the rims of test tube dry to make a dry cell button.7. Added two drops of Anti-IgG to the dry cell buttons mix gently and centrifuge.8. Re-suspended gently and examine each cell button for agglutination.9. Recorded results in the appropriate column on the worksheet10. Confirmed all negative results by adding one drop Check cells to all tubes showing no agglutination and centrifuge 15 seconds.11. Gently re-suspended and examine the cell buttons for agglutination. Agglutination should be present in this step or the test is invalid.12. Read, graded and recorded results.Results:Patient sample #1 was determined to be AB Rh positivePatient sample #2 was determined to be O Rh positivePatient sample #3 was determined to be A Rh negativeWeak D:Patient sample #3 incubated for15 minutes at 37 oC showed no agglutinations presentPatient sample #3 with added Anti-IgG showed no agglutinations presentPatient sample #3 with added Check Cells showed very small agglutinates, turbid background

Discussion:A negative result in the immediate spin phase and no agglutination in the D tube following incubation indicate a negative test for weak D. No agglutination was present in the DC tube. Lack of agglutination is a negative test and the patient is considered truly D negative. Agglutination in the DC tube invalidates the test. Check cells were added to confirm all the negative results and agglutination occurred. When adding Check cells if no agglutination is present at this stage of the procedure, the test is invalid and the antiglobulin phase must be repeated. In the results obtain there is a possible source of error that may have occurred due to the cells being washed only once and not 3 times. This is a potential source of interference in the final result due to this.

Conclusion: The objective was not achieved as the weak D expression was not present. The results after incubation was graded 0 as no reaction was observed from Patient sample #3 with an A Rh negative blood type. When Anti-IgG was added no reaction was observed and this was graded as 0. Addition of the Check cells produced a 1+ Agglutinate. I was expecting a 2+ Agglutinate result but I believe this occurred due to the fact that the sample was only washed once. A true weak D should give at least a 2+ positive result. Weaker results may be due to mixed field agglutination in an Rh negative individual who received Rh positive blood, or vice-versa. It was learnt that check cells are used to verify negative results and the sample was truly Rh negative with no D antigen present.

Reference: Weak D Testing. (n.d.). Retrieved March 26, 2015. Blood Bank. (n.d.). Retrieved March 26, 2015.IMMUNOHAEMATOLOGY 411 Lecturer: Ms. M. CarrilloPage 2